TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ATNM

Actinium Pharmaceuticals Inc

Healthcare · Biotechnology

1.20$ +2.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Actinium Pharmaceuticals Inc (ATNM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 52 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ATNM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
7.6 27 23 18 15 12 66 80 114 81 77 52
7.4 26 22 18 14 10 65 80 111 78 75 49
6.7 26 21 17 14 9.3 64 78 109 77 73 48
6.7 26 21 17 14 9.3 64 78 109 77 73 48
0.1 0.1 0.1 0.1 0.1 1.1 1.0 0.6 2.9
9.5 4.6 4.5 4.7 6.1 6.0 5.1 6.8 48 45 44 44
9.5 4.6 4.5 4.7 6.1 5.3 4.8 6.8 11 8.5 8.1 8.0
0.3 0.3 0.3 0.0 0.2 0.7 0.4 0.3 0.5 0.5 0.6 0.7
2.3 1.5 4.2 4.7 5.8 4.6 4.3 5.5 10 8.0 7.6
-1.9 22 18 14 8.8 5.6 61 74 66 36 33 7.8
-91 -112 -137 -163 -187 -209 -231 -256 -289 -338 -376 -410
0.9 1.3 1.6 2.2 3.5 5.0 12 21 24 27 30 31

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?